Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a review for practitioners

被引：42
|
作者：
Brown, Kelly A. [1 ]
Samuel, Sharmeen [1 ]
Patel, Dilip R. [1 ]
机构：
[1] Western Michigan Univ, Homer Stryker MD Sch Med, Dept Pediat & Adolescent Med, 1000 Oakland Dr, Kalamazoo, MI 49008 USA
来源：
TRANSLATIONAL PEDIATRICS | 2018年 / 7卷 / 01期
关键词：
Attention-deficit/hyperactivity disorder (ADHD); stimulants; non-stimulant medication; methylphenidate; amphetamine; alpha-2-agonists; DEFICIT/HYPERACTIVITY DISORDER; CARDIOVASCULAR EVENTS; STIMULANT-DRUGS; UNITED-STATES; ADHD DRUGS; ATOMOXETINE; METHYLPHENIDATE; SAFETY; PHARMACOTHERAPY; RELEASE;
D O I：
10.21037/tp.2017.08.02
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioral disorder in children and adolescents. ADHD affects multiple aspects of an individual's life and functioning in family, social, and academic realms. Effective management of ADHD is necessary for children and adolescents and may include non-pharmacologic treatments, pharmacologic therapy including use of stimulant and non-stimulant medications, or a combination of the different treatment modalities. In general, medications used to treat ADHD are safe and effective. Medical practitioners can follow a step-wise approach in the selection and adjustment of pharmacologic agents to treat ADHD, while working closely with families, caregivers, and other medical and educational professionals to form appropriate treatment plans. This article reviews practical aspects of pharmacological treatment of ADHD in children and adolescents.
引用
收藏
页码：36 / 47
页数：12
相关论文
共 50 条
  • [21] Correlation between attention deficit hyperactivity disorder and bipolar disorder in children and adolescents: Systematic review
    Bien, Martyna Patrycja
    Adamczewska, Klaudia Aleksandra
    Wilczynski, Krzysztof Maria
    Cichon, Lena
    Jelonek, Ireneusz
    Janas-Kozik, Malgorzata
    PSYCHIATRIA POLSKA, 2023, 57 (02) : 375 - 394
  • [22] Diagnosis and management of children with attention deficit hyperactivity disorder
    Prahbhjot Malhi
    Pratibha Singhi
    The Indian Journal of Pediatrics, 2001, 68 (6) : 547 - 555
  • [23] The management of attention deficit-hyperactivity disorder in children
    Schellack, Natalie
    Meyer, Hannalie
    SA PHARMACEUTICAL JOURNAL, 2012, 79 (10) : 12 - 20
  • [24] Bacomind® For the Management of Attention Deficit Hyperactivity Disorder in Children
    Dave, Usha Pinakin
    Dingankar, Sunila Rajeev
    Saxena, Vinod Swaroop
    Allan, Joseph Joshua
    Bethapudi, Bharathi
    Agarwal, Amit
    INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 : S121 - S121
  • [25] Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
    Storebo, Ole Jakob
    Storm, Maja Rosenberg Overby
    Ribeiro, Johanne Pereira
    Skoog, Maria
    Groth, Camilla
    Callesen, Henriette E.
    Schaug, Julie Perrine
    Rasmussen, Pernille Darling
    Huus, Christel-Mie L.
    Zwi, Morris
    Kirubakaran, Richard
    Simonsen, Erik
    Gluud, Christian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (03):
  • [26] Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
    Storebo, Ole Jakob
    Ramstad, Erica
    Krogh, Helle B.
    Nilausen, Trine Danvad
    Skoog, Maria
    Holmskov, Mathilde
    Rosendal, Susanne
    Groth, Camilla
    Magnusson, Frederik L.
    Moreira-Maia, Carlos R.
    Gillies, Donna
    Rasmussen, Kirsten Buch
    Gauci, Dorothy
    Zwi, Morris
    Kirubakaran, Richard
    Forsbol, Bente
    Simonsen, Erik
    Gluud, Christian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (11):
  • [27] Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder
    Witcher, JW
    Long, A
    Smith, B
    Sauer, JM
    Heilgenstein, J
    Wilens, T
    Spencer, T
    Biederman, J
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 (01) : 53 - 63
  • [28] Efficacy of atomoxetine in children and adolescents with attention deficit/hyperactivity disorder
    Yamamuro, K.
    Ueda, J.
    Takada, R.
    Yoshikawa, H.
    Aoki, C.
    Inoue, Y.
    Azechi, T.
    Yamamoto, S.
    Furuyama, T.
    Kishimoto, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S713 - S714
  • [29] Effectiveness of strattera in children and adolescents with attention deficit hyperactivity disorder
    Vakula, I. N.
    Vasyanina, Yu Sh.
    Gorbunova, Z. H.
    Nikiforova, E. Yu.
    Ponomarenko, E. I.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2009, 109 (08) : 42 - 44
  • [30] Efficacy of Attention Deficit Hyperactivity Disorder treatments in children and adolescents
    Jarque Fernandez, Sonia
    ANUARIO DE PSICOLOGIA, 2012, 42 (01): : 19 - U134
12345